Wu et al. [24] knocked-down and overexpressed p53 in various lung cancer cells, their results showed that the cytoplasmic APEX1 expression elevated by p53 aberration may be used to predict poor survival and recurrence of NSCLC patients. This evidence concerns the gene TP53 and non-small cell lung carcinoma.